drugset / Trial / NCT05322616
Single-Ascending Dose Study of JK07 in Subjects With HFpEF
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A phase 1, randomized, double-blind, placebo-controlled single-ascending dose study to assess JK07 in adult subjects with heart failure with preserved ejection fraction.
Timeline
- Start
- 2022-10-21
- Primary completion
- 2023-05-26
- Completion
- 2023-05-26
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | JK07 | Protein / enzyme biologic | — | Intravenous |